切换至 "中华医学电子期刊资源库"

中华腔镜泌尿外科杂志(电子版) ›› 2021, Vol. 15 ›› Issue (05) : 378 -382. doi: 10.3877/cma.j.issn.1674-3253.2021.05.004

临床研究

68Ga-PSMA-11 PET/CT延迟显像探测前列腺癌根治术后盆腔复发的价值
秦露平1, 吕杰2, 李名钊3, 李建芳1, 谢良骏1, 李锦萍1, 程木华1,()   
  1. 1. 510630 广州,中山大学附属第三医院核医学科
    2. 510120 广州医科大学附属第一医院核医学科
    3. 510630 广州,中山大学附属第三医院泌尿外科
  • 收稿日期:2021-06-15 出版日期:2021-10-01
  • 通信作者: 程木华

The value of 68Ga-PSMA-11 PET/CT delayed imaging in the detection of pelvic recurrence after radical prostatectomy

Luping Qin1, Jie Lv2, Mingzhao Li3, Jianfang Li1, Liangjun Xie1, Jinping Li1, Muhua Cheng1,()   

  1. 1. Department of Nuclear Medicine, the Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510630, China
    2. Department of Nuclear Medicine, the First Affiliated Hospital of Guangzhou Medical University, 510120 Guangzhou, China
    3. Department of Urology, the Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510630, China
  • Received:2021-06-15 Published:2021-10-01
  • Corresponding author: Muhua Cheng
引用本文:

秦露平, 吕杰, 李名钊, 李建芳, 谢良骏, 李锦萍, 程木华. 68Ga-PSMA-11 PET/CT延迟显像探测前列腺癌根治术后盆腔复发的价值[J]. 中华腔镜泌尿外科杂志(电子版), 2021, 15(05): 378-382.

Luping Qin, Jie Lv, Mingzhao Li, Jianfang Li, Liangjun Xie, Jinping Li, Muhua Cheng. The value of 68Ga-PSMA-11 PET/CT delayed imaging in the detection of pelvic recurrence after radical prostatectomy[J]. Chinese Journal of Endourology(Electronic Edition), 2021, 15(05): 378-382.

目的

分析68Ga-前列腺特异性膜抗(PSMA)-11 PET/CT延迟显像探测前列腺癌根治术后盆腔复发的价值。

方法

回顾性纳入本院行前列腺癌根治术的患者24例。患者注射显像剂后60 min行68Ga-PSMA-11 PET/CT全身标准显像及180 min行局部盆腔延迟显像。比较标准显像及延迟显像探测盆腔复发病灶数目、大小、最大标准摄取值(SUVmax)及靶/本比(T/B)。

结果

24例患者中,盆腔复发患者17例。复发患者中标准显像阳性15例,延迟显像阳性17例。无复发患者7例,标准显像及延迟显像均呈阴性。标准显像探测盆腔复发灵敏度为82.24%(15/17),延迟显像灵敏度为100.0%(17/17),两者差异无统计学意义(χ2=2.125,P=0.145)。延迟显像比标准显像多探测10个盆腔阳性病灶。延迟显像额外发现的盆腔病灶直径4(3,8) mm比标准显像发现的盆腔病灶直径8(7,12) mm更小(U=94,P=0.004)。延迟显像病灶SUVmax10.08(6.58,15.50)与标准显像7.89(4.87,15.26)相当(U=1204,P=0.234),但延迟显像病灶T/B值55.90(30.45,109.27)明显高于标准显像32.89(21.67,55.07) (U=840,P=0.0005)。

结论

前列腺癌根治术后68Ga-PSMA-11 PET/CT延迟显像可以探测更多更小的盆腔复发病灶。

Objective

To analyze the value of 68Ga-Prostate-specific membrane antigen (PSMA)-11 PET/CT delayed imaging in the detection of pelvic recurrence after radical prostatectomy.

Methods

Twenty-four patients who underwent radical prostatectomy at our institution were retrospectively enrolled in the study. The patients received 68Ga-PSMA-11 PET/CT whole-body standard imaging at 60 min and pelvic delayed imaging at 180 min after intravenous injection of radiopharmaceutical. The number, size, maximum standard uptake (SUVmax) and target-to-background ratio (T/B) of pelvic recurrent lesions were compared between standard imaging and delayed imaging.

Results

Pelvic recurrence occurred in 17 of the 24 patients. Of the recurrent patients, standard imaging was positive in 15 cases and delayed imaging was positive in 17 cases. There were 7 cases without recurrence, and both standard imaging and delayed imaging were negative. There was no statistical difference (χ2=2.125, P=0.145) in the sensitivity of detecting pelvic recurrence between standard imaging (82.24%, 15/17) and delayed imaging (100.00%, 17/17). Delayed imaging detected 10 more pelvic positive lesions than standard imaging. The diameter 4(3, 8) mm of additional pelvic lesion detected by delayed imaging was smaller than that 8(7, 12) mm of pelvic lesion detected by standard imaging (U=94, P=0.004). The SUVmax 10.08(6.58, 15.50) of delayed imaging was similar to that of standard imaging 7.89(4.87, 15.26) (U=1204, P=0.234), however the T/B value of delayed imaging 55.90(30.45, 109.27) was significantly higher than that of standard imaging 32.89(21.67, 55.07) (U=840, P=0.0005).

Conclusion

68Ga-PSMA-11 PET/CT delayed imaging can detect more and smaller pelvic recurrent lesions after radical prostatectomy.

图1 68Ga-PSMA-11 PET/CT延迟显像额外发现髂骨病灶 注:a为67岁,男性患者,68Ga-PSMA-11 PET/CT标准显像右侧髂骨见一高密度小结节影,边界清晰,直径为4 mm,未见放射性浓聚,本底SUVmean为0.44;b为该患者68Ga-PSMA-11 PET/CT延迟显像右侧髂骨病灶见放射性浓聚,SUVmax为2.65,本底SUVmean为0.17,T/B为15.59;c为该患者经过内分泌治疗后1年余复查68Ga-PSMA-11 PET/CT标准显像,原右侧髂骨病灶直径增大至9 mm,见放射性浓聚,SUVmax为32.47,本底SUVmean为0.40,T/B为81.18
[1]
Hyuna S, Jacques F, Rebecca LS, et al. Global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249.
[2]
Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2): 115-132.
[3]
李星, 曾晓勇. 中国前列腺癌流行病学研究进展[J]. 肿瘤防治研究, 2021, 48(1): 98-102.
[4]
Eiber M, Kroenke M, Wurzer A, et al. 18F-rhPSMA-7 PET for the Detection of Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy[J]. J Nucl Med, 2020, 61(5): 696-701.
[5]
瞿旻, 高旭, 侯建国, 等. 前列腺癌患者根治术后生化复发危险因素的单中心研究[J]. 中华泌尿外科杂志, 2015, 36(8): 573-577.
[6]
Fendler WP, Eiber M, Beheshti M, et al. 68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0[J]. Eur J Nucl Med Mol Imaging, 2017, 44(6): 1014-1024.
[7]
田蓉蓉, 赵铭, 周洁, 等. 18F-PSMA-1007 PET/CT对低PSA水平前列腺癌复发的检测价值[J]. 中华核医学与分子影像杂志, 2020, 40(10): 589-594.
[8]
周文瑶, 张俊. 前列腺癌PSMA PET显像剂研究进展[J]. 中华核医学与分子影像杂志, 2020, 40(12): 755-760.
[9]
Cheng G, Torigian DA, Zhuang H, et al. When should we recommend use of dual time-point and delayed time-point imaging techniques in FDG PET?[J]. Eur J Nucl Med Mol Imaging, 2013, 40(5): 779-787.
[10]
Schmuck S, Nordlohne S, von Klot C, et al. Comparison of standard and delayed imaging to improve the detection rate of [68Ga]PSMA I&T PET/CT in patients with biochemical recurrence or prostate-specific antigen persistence after primary therapy for prostate cancer[J]. Eur J Nucl Med Mol Imaging, 2017, 44(6): 960-968.
[11]
Sahlmann C, Meller B, Bouter C, et al. Biphasic 68Ga-PSMA-HBED-CC-PET/CT in patients with recurrent and high-risk prostate carcinoma[J]. Eur J Nucl Med Mol Imaging, 2016, 43(5): 898-905.
[12]
Schmuck S, Mamach M, Wilke F, et al. Multiple Time-Point 68Ga-PSMA I&T PET/CT for Characterization of Primary Prostate Cancer[J]. Clin Nucl Med, 2017, 42(6): e286-e293.
[13]
Beheshti M, Manafi-Farid R, Geinitz H, et al. Multiphasic 68Ga-PSMA PET/CT in the detection of early recurrence in prostate cancer patients with a psa level of less than 1 ng/ml: a prospective study of 135 patients[J]. J Nucl Med, 2020, 61(10): 1484-1490.
[14]
Derlin T, Weiberg D, von Klot C, et al. (68)Ga-PSMA I&T PET/CT for assessment of prostate cancer: evaluation of image quality after forced diuresis and delayed imaging[J]. Eur Radiol, 2016, 26(12): 4345-4353.
[15]
Eiber M, Maurer T, Souvatzoglou M, et al. Evaluation of hybrid (6)(8)ga-psma ligand pet/ct in 248 patients with biochemical recurrence after radical prostatectomy[J]. J Nucl Med, 2015, 56(5): 668-674.
[1] 崔占斌, 乔军利, 张丽丽, 韩明强. 尿碘水平与甲状腺乳头状癌患者术后复发危险度分层的相关性[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 615-618.
[2] 陈垚, 徐伯群, 高志慧. 改良式中间上入路根治术治疗甲状腺癌的有效性安全性研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 619-622.
[3] 阿冲罗布, 陈颖, 谢德坤. 腹腔镜外囊完整剥离术治疗肝包虫病效果及对患者肝功能、预后的影响[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 666-669.
[4] 郑泽坤, 刘卓恒, 邹浩, 胡会元, 李妲, 吴巍. 扩大根治性手术切除复发性巨大腹膜后去分化脂肪肉瘤1例[J]. 中华普外科手术学杂志(电子版), 2023, 17(05): 588-590.
[5] 梁健, 何京伟, 关文峰, 梁其炎, 冯能卓, 黄亦欣, 覃文超. 多参数MRI与超声认知融合引导下前列腺靶向穿刺的前瞻性研究[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(06): 558-562.
[6] 梅津熠, 王燕, 瞿旻, 董振阳, 周增辉, 沈显琦, 李嘉伦, 高旭. 机器人前列腺癌根治术中"膀胱外中叶"的处理[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(05): 429-433.
[7] 李腾成, 谭益元, 黄群雄, 吴杰英, 肖恒军, 胡成, 李茂胤, 高新, 狄金明. 机器人腹腔镜后入路完全筋膜内根治性前列腺切除术治疗早期前列腺癌[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(05): 452-456.
[8] 罗辉, 熊珍珍, 黄令杰, 林山, 李金雨. 盆腔淋巴结大小对膀胱癌复发的影响[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(05): 495-499.
[9] 邢晓伟, 刘雨辰, 赵冰, 王明刚. 基于术前腹部CT的卷积神经网络对腹壁切口疝术后复发预测价值[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 677-681.
[10] 姜明, 罗锐, 龙成超. 闭孔疝的诊断与治疗:10年73例患者诊疗经验总结[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 706-710.
[11] 蒋正东, 李徐奇, 王曙逢, 魏光兵. 复发性腹股沟疝的腹腔镜手术策略及疗效观察[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(05): 539-543.
[12] 张文华, 陶焠, 胡添松. 不同部位外生型肝癌临床病理特点及其对术后肝内复发和预后影响[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 651-655.
[13] 叶文涛, 吴忠均, 廖锐. 癌旁组织ALOX15表达与肝癌根治性切除术后预后的关系[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 708-712.
[14] 张政赢, 鞠阳, 刘晓宁. 二甲双胍对2型糖尿病患者大肠腺瘤术后复发的影响[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 485-488.
[15] 符梅沙, 周玉华, 李慧, 薛春颜. 淋巴细胞免疫治疗对复发性流产患者外周血T淋巴细胞亚群分布与PD1/PD-L1表达的影响及意义[J]. 中华临床医师杂志(电子版), 2023, 17(06): 726-730.
阅读次数
全文


摘要